Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Zhenzhou
Clinical trial register · China

Clinical Trials in Zhenzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5586 Shanghai 3885 Guangzhou 3356 Hangzhou 1825 Wuhan 1342

Trials with a site in Zhenzhou

12 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG
NCT07918781Postoperative Atrial Fibrillation, Coronary Artery Disease
China National Center for Cardiovascular Diseases
Not applicable
1,470
Beijing, Guangzhou, Zhenzhou, Changsha, Nanjing
2026-12-01
Recruiting
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
NCT07646678Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2
Takeda
Phase 2/3
500
Xicheng, Guangzhou, Zhenzhou
2026-06-11
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
24
Zhenzhou
2026-05-26
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
30
Zhenzhou
2026-03-16
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
180
Zhenzhou, Yantai, Shanghai
2026-02-01
Not yet open
Zeng Changhao
Not applicable
474
Suzhou, Zhenzhou
2026-02
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
40
Zhenzhou
2024-09-20
Active, closed
Tianjin Medical University General Hospital
Phase 2/3
102
Hefei, Lanzhou, Shijiazhuang, Harbin, Zhenzhou, Ordos, Changzhou, Suzhou
2024-07-09
Recruiting
Shenzhen Genocury Biotech Co., Ltd.
Not applicable
20
Zhenzhou
2023-09-07
Recruiting
Suping ZHANG
Phase 4
60
Zhenzhou
2023-09-01
Recruiting
Shanghai Hongdian Medical CO., LTD
Not applicable
180
Chongqing, Xiamen, Lanzhou, Guangzhou, Guiyang, Harbin, Zhengzhou, Zhenzhou
2023-03-31
Recruiting
Ascentage Pharma Group Inc.
Phase 1/2
123
Beijing, Chongqing, Guangzhou, Nanning, Guiyang, Shijiazhuang, Zhenzhou, Wuhan
2020-08-31
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-china/city/zhenzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 12 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies with a site in Zhenzhou.

How many clinical trials are recruiting in Zhenzhou?

8 of the 12 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zhenzhou), 12 studies
PhaseStudiesRecruitingShare
Not applicable5241.7%
Phase 12216.7%
Phase 2/32116.7%
Phase 1/2118.3%
Phase 2118.3%
Phase 4118.3%

Most active sponsors

Lead sponsors with the most studies (Zhenzhou)
Lead sponsorStudiesRecruiting
Haisco Pharmaceutical Group Co., Ltd.22
Ascentage Pharma Group Inc.11
China National Center for Cardiovascular Diseases10
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine10
Shanghai Hongdian Medical CO., LTD11
Shenzhen Genocury Biotech Co., Ltd.11
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.11
Suping ZHANG11
Takeda11
Tianjin Medical University General Hospital10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.